================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
----------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) January 29, 2004
EMISPHERE TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its charter)
DELAWARE 1-10615 13-3306985
---------------------------- ------------- -----------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification Number)
765 OLD SAW MILL RIVER ROAD, TARRYTOWN, NEW YORK 10591
-----------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(914) 347-2220
-----------------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
-----------------------------------------------------------------
(Former name or former address, if changed since last report)
================================================================================
ITEM 5. OTHER EVENTS.
On January 29, 2004, Emisphere Technologies, Inc. issued a press release
announcing preliminary results from the first multiple-dose clinical study of an
oral insulin tablet using its eligen(TM) technology. Attached hereto and
incorporated by reference herein as Exhibit 99.1 is a copy of such press
release.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits:
Exhibit Number Description
-------------- -----------
99.1 Press Release of the Company, dated January 29, 2004.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EMISPHERE TECHNOLOGIES, INC.
Dated: January 30, 2004
By: /s/ Michael Goldberg
-------------------------------------
Name: Michael Goldberg
Title: Chief Executive Officer
3